Key result
Pacemaker therapy provides key support in AF management, particularly for bradycardia and post-AV junction ablation.
Pacemaker therapy serves as an important adjunctive treatment in atrial fibrillation, particularly for managing bradycardia and in combination with AV node ablation for refractory symptoms.
Pacemaker therapy remains adjunctive for bradycardia prevention and post-AVJ ablation in refractory AF; leaves open broader preventive algorithm efficacy pending prospective trials.
There are a number of applications for pacemaker therapy in the management of Atrial Fibrillation (AF). The most frequent indication for pacing in AF is to prevent bradycardia in patients with rapid ventricular response and sinus node dysfunction. For elderly patients or patients with significant medical comorbidities who have highly symptomatic, drug-refractory AF, pacemaker implantation and atrioventricular (AV) junction ablation can be an effective alternative therapy. Pacing may also decrease symptoms during atrial fibrillation by regularizing the ventricular rate. Other pacing strategies attempt to decrease AF recurrence, but these algorithms have demonstrated only limited success. Although pacing is generally not considered primary therapy for AF, it may play an important adjunctive role in the management of patients with AF.
No takes yet. Share an insight, caveat, or question.
Shirley Park (2019) conducted a review in Atrial Fibrillation. Pacemaker Therapy was evaluated. Pacemaker therapy plays an important adjunctive role in the management of atrial fibrillation, particularly for preventing bradycardia and supporting patients after atrioventricular junction ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: